Noninvasive technique to assess brain tumors in children and make treatment less toxic

by Chris Speight,University of BirminghamCredit: CC0 Public DomainGround-breaking research by the University of Birmingham has discovered a new technique to assess the aggressiveness of childhoo

Updated on: December 20,2023 24

Noninvasive technique to assess brain tumors in children and make treatment less toxic

by Chris Speight,University of BirminghamCredit: CC0 Public DomainGround-breaking research by the University of Birmingham has discovered a new technique to assess the aggressiveness of childhoo

Updated on:December 20,2023 24

New fast, effective way to detect cancer stem cells

New fast, effective way to detect cancer stem cellsby Fram Dinshaw,McMaster UniversityGraphical abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.101108McMaster

Updated on: October 28,2023 8

New fast, effective way to detect cancer stem cells

New fast, effective way to detect cancer stem cellsby Fram Dinshaw,McMaster UniversityGraphical abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.101108McMaster

Updated on:October 28,2023 8

Two cancer-causing genes work together to promote metastasis

byeLifeCredit: CC0 Public DomainCancer-promoting genes MYC and TWIST1 co-opt immune system cells to enable cancer cells to spread, but blocking a key step in this process can help prevent the di

Updated on: December 20,2023 21

Two cancer-causing genes work together to promote metastasis

byeLifeCredit: CC0 Public DomainCancer-promoting genes MYC and TWIST1 co-opt immune system cells to enable cancer cells to spread, but blocking a key step in this process can help prevent the di

Updated on:December 20,2023 21

AI's Breakthroughs in Ovarian Cancer Diagnosis and Treatment

Updated on: June 12,2024 0

AI's Breakthroughs in Ovarian Cancer Diagnosis and Treatment

Updated on:June 12,2024 0

Localizing BRCA gene mutations to better treat ovarian cancer

byUniversity of GenevaDistribution of mutations in BRCA1 and BRCA2. A. Graphical summary of BRCA1 and BRCA2 mutations. Mutation plot was generated using cBioPortal MutationMapper tool. Black = n

Updated on: December 20,2023 10

Localizing BRCA gene mutations to better treat ovarian cancer

byUniversity of GenevaDistribution of mutations in BRCA1 and BRCA2. A. Graphical summary of BRCA1 and BRCA2 mutations. Mutation plot was generated using cBioPortal MutationMapper tool. Black = n

Updated on:December 20,2023 10

New treatment combination shows promise for metastatic colorectal cancer patients with rare genetic mutation

An international Phase 3 clinical trial found that metastatic colorectal cancer patients with a rare genetic tumor mutation called KRAS G12C experienced superior progression-free survival rates compar

Updated on: November 07,2023 17

New treatment combination shows promise for metastatic colorectal cancer patients with rare genetic mutation

An international Phase 3 clinical trial found that metastatic colorectal cancer patients with a rare genetic tumor mutation called KRAS G12C experienced superior progression-free survival rates compar

Updated on:November 07,2023 17

First test of anti-cancer agent PAC-1 in human clinical trials shows promise

by Diana Yates,University of Illinois at Urbana-ChampaignProcaspase-3 (PC-3) expressions in diverse tumor histologies categorized as moderate-to-strong immunostaining intensities. Credit:B

Updated on: December 27,2023 6

First test of anti-cancer agent PAC-1 in human clinical trials shows promise

by Diana Yates,University of Illinois at Urbana-ChampaignProcaspase-3 (PC-3) expressions in diverse tumor histologies categorized as moderate-to-strong immunostaining intensities. Credit:B

Updated on:December 27,2023 6

Selpercatinib Significantly Improves PFS, Responses in Advanced RET+ Medullary Thyroid Cancer

October 21, 2023Gina MauroSelpercatinib resulted in a statistically significant improvement in progression-free survival and overall response rate compared with cabozantinib or vandetanib in patients

Updated on: October 24,2023 2

Selpercatinib Significantly Improves PFS, Responses in Advanced RET+ Medullary Thyroid Cancer

October 21, 2023Gina MauroSelpercatinib resulted in a statistically significant improvement in progression-free survival and overall response rate compared with cabozantinib or vandetanib in patients

Updated on:October 24,2023 2

Sexual side effects of cancer treatment often unaddressed with female patients

byAmerican Society for Radiation OncologyCredit: Pixabay/CC0 Public DomainA new study finds that sexual side effects of cancer treatment are discussed far less frequently with female patients th

Updated on: December 18,2023 10

Sexual side effects of cancer treatment often unaddressed with female patients

byAmerican Society for Radiation OncologyCredit: Pixabay/CC0 Public DomainA new study finds that sexual side effects of cancer treatment are discussed far less frequently with female patients th

Updated on:December 18,2023 10

Estrogen Receptor Mutation Prospects in Endometrial Cancer Treatment

byHemalatha Manikandanon August 22, 2023Inhibiting CDK9, a protein that works withestrogen receptors, was effective at minimizing the proliferation ofendometrial cancerce

Updated on: December 19,2023 32

Estrogen Receptor Mutation Prospects in Endometrial Cancer Treatment

byHemalatha Manikandanon August 22, 2023Inhibiting CDK9, a protein that works withestrogen receptors, was effective at minimizing the proliferation ofendometrial cancerce

Updated on:December 19,2023 32

Basic research opens up new therapeutic opportunities for fighting leukemia

byUniversity of Veterinary Medicine—ViennaGenome-wide CRISPR/Cas9-based loss-of-function screen identifies genetic dependencies of STAT3Y640F-driven cells a) Schematic illustration of a competit

Updated on: December 25,2023 11

Basic research opens up new therapeutic opportunities for fighting leukemia

byUniversity of Veterinary Medicine—ViennaGenome-wide CRISPR/Cas9-based loss-of-function screen identifies genetic dependencies of STAT3Y640F-driven cells a) Schematic illustration of a competit

Updated on:December 25,2023 11

Pembrolizumab Monotherapy Displays Efficacy in Rare Sarcomas

The PD-1 inhibitor pembrolizumab (Keytruda) displayed activity with a manageable safety profile in patients with certain rare and ultra-raresarcoma histotypes, according to findings from the phase 2 A

Updated on: November 07,2023 6

Pembrolizumab Monotherapy Displays Efficacy in Rare Sarcomas

The PD-1 inhibitor pembrolizumab (Keytruda) displayed activity with a manageable safety profile in patients with certain rare and ultra-raresarcoma histotypes, according to findings from the phase 2 A

Updated on:November 07,2023 6